Citation Impact
Citing Papers
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Heparin Absorption Across the Intestine: Effects of Sodium N-[8-(2-Hydroxybenzoyl)Amino]Caprylate in Rat In Situ Intestinal Instillations and in Caco-2 Monolayers
1997
Considerations with the use of biological therapy in the treatment of rheumatoid arthritis
2004
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Photodynamic Therapy
1998 Standout
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo
1999 Standout
31P magnetic resonance spectroscopy as predictor of clinical response in human extremity sarcomas treated by single dose TNF‐α+ melphalan isolated limb perfusion
1995
The history, properties, and biological effects of cachectin
1988 StandoutNobel
Tumor necrosis factor, cancer and anticancer therapy
2004
Cachectin: A Hormone that Triggers Acute Shock and Chronic Cachexia
1988
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
1990 Standout
Pharmacokinetic aspects of biotechnology products
2004
Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.
1993
Soft-Tissue Sarcomas in Adults
2005 Standout
Mono‐N‐Carboxymethyl Chitosan (MCC), a Polyampholytic Chitosan Derivative, Enhances the Intestinal Absorption of Low Molecular Weight Heparin Across Intestinal Epithelia In Vitro and In Vivo
2001
Osteoporosis: now and the future
2011 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Parathyroid Hormone as an Anabolic Skeletal Therapy
2005
Suppression of Syndecan-1 Expression in Endothelial Cells by Tumor Necrosis Factor-α
1996
Delivery of LMW Heparin via Surface Coated Chitosan/peg-Alginate Microspheres Prevents Thrombosis
2002
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Paradoxical effects of tumour necrosis factor in experimental ovarian cancer
1989
TREM-1 amplifies inflammation and is a crucial mediator of septic shock
2001 StandoutNature
A CAT reporter construct allows ultrasensitive estimation of TNF synthesis, and suggests that the TNF gene has been silenced in non-macrophage cell lines.
1991 StandoutNobel
Heat-inducible TNF-α gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy
2001
Identification and characterization of a new member of the TNF family that induces apoptosis
1995 Standout
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Visualization of Thyroglossal Duct Cyst in Differentiated Thyroid Cancer Patient
2010
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Type 2 diabetes
2017 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Dendrimers as a Carrier for Pulmonary Delivery of Enoxaparin, a Low-Molecular Weight Heparin
2007
Cyclodextrins as Functional Excipients: Methods to Enhance Complexation Efficiency
2012
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Heparin and Low-Molecular-Weight Heparin
1998
Acylated non-α-amino acids as novel agents for the oral delivery of heparin sodium, USP
1998
Cytokine-associated tissue injury and lethality in mice: A comparative study
1991
Inflammation and cancer: back to Virchow?
2001 Standout
Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules
2012
Addicted to Death
2004
Cells secreting tumour necrosis factor show enhanced metastasis in nude mice
1990
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Mesoporous Materials for Drug Delivery
2007 Standout
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Tumour necrosis factor and cancer
2009
Recurrent miscarriage
2006 Standout
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
1997 StandoutNature
Cancer-related inflammation
2008 StandoutNature
Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents.
1987
Mechanisms of Anabolic Therapies for Osteoporosis
2007
Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis.
1989 StandoutNobel
New Insulins and New Aspects in Insulin Delivery
2015
Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies.
1996
Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology
2006 Standout
Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
1992 StandoutNobel
1,2-Benzisothiazol-3-one 1,1-Dioxide Inhibitors of Human Mast Cell Tryptase
1998
Complexation of Polyoxometalates with Cyclodextrins
2015 StandoutNobel
Polymeric Particulates to Improve Oral Bioavailability of Peptide Drugs
2005
The Current State of Peptide Drug Discovery: Back to the Future?
2017
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.
1988 StandoutNobel
Regulation of neutrophil migration and superoxide production by recombinant tumor necrosis factors-alpha and -beta: comparison to recombinant interferon-gamma and interleukin-1 alpha
1987
Structure and Function of Lipopolysaccharide Binding Protein
1990 StandoutScience
Photodegradable Hydrogels for Dynamic Tuning of Physical and Chemical Properties
2009 StandoutScience
Advances in biomaterials, drug delivery, and bionanotechnology
2003
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
1993 Standout
Functional Role of Type I and Type II Interferons in Antiviral Defense
1994 StandoutScience
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties.
1988 StandoutNobel
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Novel photodynamic effects of a benzophenothiazine on two different murine sarcomas.
1994
PeroralRoute: An Opportunity for Protein and Peptide Drug Delivery
2001
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
1990 StandoutScience
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
1996 StandoutScienceNobel
Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors
1991
Cachectin/TNF and IL-1 Induced by Glucose-Modified Proteins: Role in Normal Tissue Remodeling
1988 Science
Differential antigen burden modulates the gamma interferon but not the immunoglobulin response in mice that vary in susceptibility to Sendai virus pneumonia
1995 StandoutNobel
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
1993 StandoutScience
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells.
1993 StandoutNobel
The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity.
1988
Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses.
1988
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
Therapeutic effects of monoclonal antibody g250, interferons and tumor necrosis factor, in mice with renal‐cell carcinoma xenografts
1994
The Pathogenesis of Sepsis
1991
The role of cachectin/TNF in endotoxic shock and cachexia
1988 StandoutNobel
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Induction of Type I Diabetes by Interferon-α in Transgenic Mice
1993 Science
Works of R Baughman being referenced
Pharmacokinetics of Recombinant Murine Interferon-γ and Human Interferon-αA/D(Bgl) Administered in Concert and Their Influence on Natural Killer Cell Function in Mice
1988
Oral low–molecular weight heparin and delivery agent prevents jugular venous thrombosis in the rat
1999
Oral Delivery of Sodium Cromolyn: Preliminary Studies In Vivo and In Vitro
1996
Stability Study of Drug-loaded Proteinoid Microsphere Formulations during Freeze-drying
1994
Oral Delivery of Biologically Active Parathyroid Hormone
2001
Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin
2016
Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.
1987
Pharmacokinetic Characterization of the Novel Pulmonary Delivery Excipient Fumaryl Diketopiperazine
2010
ChemInform Abstract: N‐Acylated α‐Amino Acids as Novel Oral Delivery Agents for Proteins.
1996
Lingual thyroid and lingual thyroglossal tract remnants
1972
Method for assessing the stability of proteinoid microspheres
1994
4-[4-[(2-Hydroxybenzoyl)amino]phenyl]butyric Acid as a Novel Oral Delivery Agent for Recombinant Human Growth Hormone
1996
Orally Administered Unfractionated Heparin With Carrier Agent Is Therapeutic for Deep Venous Thrombosis
2000
Synthesis and Evaluation of Compounds That Facilitate the Gastrointestinal Absorption of Heparin
1998
Oral Delivery of Anticoagulant Doses of Heparin
1998